Submit an abstract by July 10 for #SABCS24 , December 10-13, 2024. Learn more:
bit.ly/3VnH7dn

.Sara Tolaney and #SABCS24 program director Kate Lathrop discussed the phase III KEYNOTE-522 trial, which recently met its overall survival endpoints in patients with high-risk early-stage TNBC. Watch now on #SABCSSnippets :
bit.ly/3R4pRHB
UT Health San Antonio MD Anderson

The preliminary program for #SABCS24 (December 10-13) is now available in PDF format. Learn more and download a copy:
bit.ly/4e1cnGc

Abstract submission is now open for the San Antonio Breast Cancer Symposium, December 10-13, 2024.
Abstract deadline: July 10. Learn more:
bit.ly/3yAFpwo
#SABCS24

Nominate a colleague by May 31 for the William L. McGuire Award, which honors an investigator whose sustained achievements in translational/clinical research have advanced our understanding of the pathogenesis or outcome of breast cancer patients.
bit.ly/3wBKcwT
#SABCS24

Abstract submission is now open for the San Antonio Breast Cancer Symposium, December 10-13, 2024.
Abstract deadline: July 10. Learn more:
bit.ly/4btDzeO
#SABCS24

Nominate a colleague by May 31 for the William L. McGuire Award, which honors an investigator whose sustained achievements in translational/clinical research have advanced our understanding of the pathogenesis or outcome of breast cancer patients.
bit.ly/4dHk30r
#SABCS24

Abstract submission is now open for the San Antonio Breast Cancer Symposium, December 10-13, 2024.
Abstract deadline: July 10. Learn more:
bit.ly/3K4giEJ
#SABCS24

.VIRGINIA KAKLAMANI and Aditya Bardia, MD discussed the Phase III Destiny-Breast06 trial, in which TDXd demonstrated improvement in PFS in patients with HR-positive, HER2-low and HER2-ultralow metastatic breast cancer. Watch now on SABCS Snippets:
bit.ly/3JHpw9q
UT Health San Antonio MD Anderson

FLAURA2 exploratory analysis discussion by Marina Garassino at #AACR24 :
🔺dynamic ctDNA analysis not useful for clinical decisions
🔹baseline detection of EGFRm is prognostic and may select for a higher degree of clinical benefit from Osi+CT
AACR

Just published concurrently with an #AACR24 poster—
ZNF397 Deficiency Triggers TET2-driven Lineage Plasticity and AR-Targeted Therapy Resistance in #ProstateCancer , by Yaru Xu, Ping Mu 🇺🇦 et al.
bit.ly/3Ucp3C8
PCF Science UTSW Simmons Cancer Center AACR

How do the results of the phase 3 TROPION-Breast01 trial change our treatment algorithm for metastatic ER+ breast cancer?
Komal Jhaveri and Julie Nangia addressed this question during #SABCS23 . Watch now on SABCS Snippets:
youtu.be/wYYgIkGDLmI?si…
AACR UT Health San Antonio MD Anderson

Jack Cuzick, PhD, head of the Queen Mary University of London Cancer Prevention Unit and #SABCS23 William L. McGuire Memorial Lecturer, reflected on his breast cancer research career with Symposium co-director Virginia Kaklamani, MD. Watch in SABCS Snippets:
youtu.be/OPi_gtNLC5A?si…
UT Health San Antonio MD Anderson AACR

We thank our program committee for creating a great #SABCS24 lineup.
VIRGINIA KAKLAMANI Carlos L. Arteaga, M.D. BalkoResearchLab Thelma Perry Brown Heide Ford Lab The Harris Lab Tari King MD MarleenKokLab Adrian Lee Julia Maués Heather McArthur, MD, MPH Debra Patt Christos Sotiriou Antoinette Tan, MD, FACP Neil Vasan Lab Ada Waks Antonio Wolff, MD (#HealthPolicyIsEconomicPolicy) Margaret Foti, PhD, MD (hc)

SABCS Snippets: At #SABCS23 , Anne May and Lindsay Peterson discussed the results of the PREFERABLE-EFFECT study, evaluating the effects of an exercise program on health-related quality of life in patients with metastatic breast cancer.
youtu.be/lJ7q-Vwwx-g AACR UT Health San Antonio MD Anderson

During #SABCS23 , Reshma Jagsi and Richard Zellars discussed 5-year outcomes of the IDEA trial, which evaluated endocrine therapy without radiotherapy after breast-conserving surgery for certain patients with Stage I breast cancer. Watch on SABCS Snippets:
youtu.be/MTKt-GDRP4M

Carey Anders, MD, of the Duke Brain and Spine Metastases Program, spoke with UT Health San Antonio MD Anderson's Andrew Brenner, MD, during #SABCS23 about the latest treatment options for CNS disease in metastatic breast cancer. Watch now in SABCS Snippets:
youtu.be/ALCXjCabIEA AACR

During #SABCS23 Dr. Debra Pratt of Texas Oncology and the Dell Medical School at the University of Texas at Austin discussed controversies in local regional care with Symposium program director Dr. Kate Lathrop.
youtu.be/KbtBsU0v2PE
AACR UT Health San Antonio MD Anderson

During #SABCS23 , Terry Mamounas, MD, discussed the phase 3 NRG Oncology/NSABP B-51/RTOG1304 trial—which shows that neoadjuvant chemotherapy may help some breast cancer patients skip regional nodal irradiation—with Hope Rugo, MD. Watch on SABCS Snippets:
youtu.be/B1FHa9AqHPA?si…

Dr. Jason Mouabbi discussed the challenges of treating lobular breast cancer—and highlighted advances presented at #SABCS23 that address these challenges—with Dr. Kate Lathrop in this episode of SABCS Snippets. Watch now:
youtu.be/5oW5JFQKipQ